Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HH.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.43.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.332NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JB.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.6.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.141NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.591NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.468NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.131 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.586NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.366NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.380NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.148NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.382NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.356NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.376NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.607NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.163NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.337NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.158NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19361.6US
B.1.602NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.289NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDHNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.507NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.178NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.273NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.211NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.474NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.297NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AH.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.280NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.597NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.72NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.85NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.66 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.72 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.133 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.5.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
AY.43.7 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.33.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used